Compugen (CGEN)
(Real Time Quote from BATS)
$1.76 USD
-0.07 (-3.83%)
Updated Sep 23, 2024 03:38 PM ET
1-Strong Buy of 5 1
F Value F Growth A Momentum F VGM
Income Statements
Fiscal Year end for Compugen Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 33 | 8 | 6 | 2 | 0 |
Cost Of Goods | 2 | 1 | 1 | 0 | 0 |
Gross Profit | 31 | 7 | 5 | 2 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 44 | 42 | 40 | 33 | 29 |
Income After Depreciation & Amortization | -13 | -35 | -35 | -32 | -29 |
Non-Operating Income | 3 | 2 | 1 | 2 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -10 | -34 | -34 | -30 | -28 |
Income Taxes | 9 | 0 | 0 | 0 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -19 | -34 | -34 | -30 | -27 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -19 | -34 | -34 | -30 | -27 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -13 | -35 | -35 | -31 | -28 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 1 | 1 |
Income After Depreciation & Amortization | -13 | -35 | -35 | -32 | -29 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 87.63 | 86.56 | 84.20 | 79.59 | 63.64 |
Diluted EPS Before Non-Recurring Items | -0.21 | -0.39 | -0.41 | -0.37 | -0.43 |
Diluted Net EPS (GAAP) | -0.21 | -0.39 | -0.41 | -0.37 | -0.43 |
Fiscal Year end for Compugen Ltd falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 6.70 | 2.56 | 33.46 | 0.00 | 0.00 |
Cost Of Goods | 1.55 | 2.10 | 2.00 | NA | 0.00 |
Gross Profit | 5.15 | 0.46 | 31.46 | NA | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 8.56 | 8.95 | 13.47 | 10.63 | 10.21 |
Income After SG&A, R&D, and Dept/Amort Expenses | -3.41 | -8.49 | 17.99 | -10.63 | -10.21 |
Non-Operating Income | 1.30 | 1.23 | 0.74 | 0.78 | 0.89 |
Interest Expense | 0.00 | NA | 0.00 | NA | 0.00 |
Pretax Income | -2.11 | -7.26 | 18.72 | -9.85 | -9.33 |
Income Taxes | 0.01 | 0.00 | 9.01 | NA | -0.05 |
Minority Interest | 0.00 | NA | 0.00 | NA | 0.00 |
Investment Gains/Losses | 0.00 | NA | 0.00 | NA | 0.00 |
Other Income/Charges | 0.00 | NA | 0.00 | NA | 0.00 |
Income From Cont. Operations | -2.12 | -7.27 | 9.71 | -9.85 | -9.28 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.12 | -7.27 | 9.71 | -9.85 | -9.28 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 89.53 | 89.51 | 88.42 | 88.31 | 87.18 |
Diluted EPS Before Non-Recurring Items | -0.02 | -0.08 | 0.11 | -0.11 | -0.11 |
Diluted Net EPS (GAAP) | -0.02 | -0.08 | 0.11 | -0.11 | -0.11 |